UAB 1640-Phase II Trial of Vosaroxin in Combination with Infusional Cytarabine in Patients with Untreated AML

Grant

Awarded By

Total Award Amount

  • 66074.00
  • Direct Costs

  • 50826.00
  • Sponsor Award Id

  • Contributor

  • Harry Erba   Principal Investigator